These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16278)

  • 1. [Tumor pH-dependent toxicity of antineoplastic agents].
    Ardenne M; Reitnauer PG
    Pharmazie; 1977 Feb; 32(2):74-5. PubMed ID: 16278
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination chemotherapy--theory and practice.
    Capizzi RL; Keiser LW; Sartorelli AC
    Semin Oncol; 1977 Jun; 4(2):227-53. PubMed ID: 327555
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacokinetic aspects of tumor tissue impairment by cancerostatics. Ways for the intensification of the induced attack in the multiple step cancer therapy. CMT-Selectine].
    von Ardenne M; von Ardenne A
    Arzneimittelforschung; 1975 Jun; 25(6):863-70. PubMed ID: 240367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A minimal toxicity approach to cancer therapy: possible role of beta-glucuronidase.
    Rubin DM; Rubin EJ
    Med Hypotheses; 1980 Jan; 6(1):85-92. PubMed ID: 7382890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Optimally spaced after-treatment with multiplicative effect. A cancer therapy principle of universal character].
    von Ardenne M
    Arch Geschwulstforsch; 1973; 42(4):324-44. PubMed ID: 4371114
    [No Abstract]   [Full Text] [Related]  

  • 6. Proton-mediated liberation of aldophosphamide from a nontoxic prodrug: a strategy for tumor-selective activation of cytocidal drugs.
    Tietze LF; Neumann M; Möllers T; Fischer R; Glüsenkamp KH; Rajewsky MF; Jähde E
    Cancer Res; 1989 Aug; 49(15):4179-84. PubMed ID: 2743306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of experimental results in clinical tumor chemotherapy (author's transl)].
    Somfai-Relle S; Sugár J
    Arch Geschwulstforsch; 1980; 50(2):132-40. PubMed ID: 7436697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General principles of cancer chemotherapy.
    Einhorn LH
    Conn Med; 1976 Mar; 40(3):159-68. PubMed ID: 765057
    [No Abstract]   [Full Text] [Related]  

  • 9. [Interactions of antineoplastic drugs].
    Robak T
    Postepy Hig Med Dosw; 1981; 35(3):243-58. PubMed ID: 6752915
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial: Anti-cancer agents with activation in strongly hyperacidified tumor tissue: CMT selectines.
    von Ardenne M; Reitnauer PG
    Agressologie; 1976; 17(5):261-4. PubMed ID: 13670
    [No Abstract]   [Full Text] [Related]  

  • 11. [Measurements and calculations on aglycon liberation from highly masked CMT selectines with beta-glucuronidase at pH 6. Realization of the principle of transport form-activity in anti-cancer drugs: theory of selectivity].
    von Ardenne M; von Ardeene A; Krüger W
    Acta Biol Med Ger; 1977; 36(9):1199-212. PubMed ID: 27052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biochemical characteristics of cancer cells--starting points for the diagnosis and therapy].
    Schauenstein E
    Wien Med Wochenschr; 1970 Jan; 120(4):45-8. PubMed ID: 4935880
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacology and toxicology of alpha-2'-deoxythioguanosine in cancer patients.
    LePage GA; Khaliq A
    Cancer Treat Rep; 1979 Jan; 63(1):53-7. PubMed ID: 421233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Constraints matrix for the concept of new cancerostatics with activation in optimally superacidulated carcinomatous tissue (author's transl)].
    Ardenne Mv; reitnauer PG
    Arch Geschwulstforsch; 1975; 45(1):34-9. PubMed ID: 239667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antitumor action of thiophosphamide against a background of glucose modification of the tumor cell mitotic cycle and a decrease in intratumor pH].
    Osinskii SP; Bubnovskaia LN
    Vopr Onkol; 1981; 27(2):51-5. PubMed ID: 6782757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Individual chemotherapy of solid tumors].
    Volm M; Mattern J
    Med Welt; 1976 Jun; 27(24):1171-6. PubMed ID: 781458
    [No Abstract]   [Full Text] [Related]  

  • 17. Acid pH in tumors and its potential for therapeutic exploitation.
    Tannock IF; Rotin D
    Cancer Res; 1989 Aug; 49(16):4373-84. PubMed ID: 2545340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics for individualized cancer chemotherapy.
    Efferth T; Volm M
    Pharmacol Ther; 2005 Aug; 107(2):155-76. PubMed ID: 15890408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer chemotherapy.
    Med Lett Drugs Ther; 1983 Jan; 25(626):1-8. PubMed ID: 6848903
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antineoplastic drugs: resistance and metabolism].
    Lavigne JG
    Union Med Can; 1976 Feb; 105(2):186-8. PubMed ID: 996993
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.